Matinas BioPharma Holdings, Inc. (MTNB)
0.1821
0.00 (0.00%)
USD |
NYAM |
Sep 09, 09:58
Matinas BioPharma Holdings Market Cap : 1.167M for Sept. 9, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 08, 2026 | 1.166M |
| September 04, 2026 | 1.166M |
| September 03, 2026 | 1.160M |
| September 02, 2026 | 1.192M |
| September 01, 2026 | 1.266M |
| August 31, 2026 | 1.266M |
| August 28, 2026 | 1.281M |
| August 27, 2026 | 1.281M |
| August 26, 2026 | 1.258M |
| August 25, 2026 | 1.264M |
| August 24, 2026 | 1.259M |
| August 21, 2026 | 1.274M |
| August 20, 2026 | 1.169M |
| August 19, 2026 | 1.544M |
| August 18, 2026 | 1.305M |
| August 17, 2026 | 1.424M |
| August 14, 2026 | 1.499M |
| August 13, 2026 | 1.493M |
| August 12, 2026 | 1.538M |
| August 11, 2026 | 1.678M |
| August 10, 2026 | 1.723M |
| August 07, 2026 | 1.813M |
| August 06, 2026 | 1.719M |
| August 05, 2026 | 1.762M |
| August 04, 2026 | 1.861M |
| Date | Value |
|---|---|
| August 03, 2026 | 1.932M |
| July 31, 2026 | 1.882M |
| July 30, 2026 | 2.033M |
| July 29, 2026 | 1.908M |
| July 28, 2026 | 1.877M |
| July 27, 2026 | 2.127M |
| July 24, 2026 | 1.546M |
| July 23, 2026 | 1.596M |
| July 22, 2026 | 1.712M |
| July 21, 2026 | 1.796M |
| July 20, 2026 | 2.016M |
| July 17, 2026 | 2.201M |
| July 16, 2026 | 2.284M |
| July 15, 2026 | 2.183M |
| July 14, 2026 | 2.241M |
| July 13, 2026 | 3.075M |
| July 10, 2026 | 4.839M |
| July 09, 2026 | 4.017M |
| July 08, 2026 | 3.946M |
| July 07, 2026 | 3.978M |
| July 06, 2026 | 4.023M |
| July 02, 2026 | 4.059M |
| July 01, 2026 | 4.042M |
| June 30, 2026 | 3.921M |
| June 29, 2026 | 4.254M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 4.782B |
| Alnylam Pharmaceuticals, Inc. | 34.66B |
| Anika Therapeutics, Inc. | 284.25M |
| Savara, Inc. | 1.121B |
| Vericel Corp. | 1.990B |
Market Cap Related Metrics
| Price to Book Value | 0.6481 |
| Price | 0.1821 |
| Earnings Yield | -659.5% |